Cornell University
View map

Come learn about the company behind the first genetically modified animal approved by the FDA for human consumption. AquAdvantage salmon grow to market weight in about half the time. Dave Conley is the director of coorporate communications at AquaBounty Technologies and will be speaking on the many economic, environmental, and health benefits of the AquAdvantage salmon. 

The event is organized by the Cornell Biotechnology Club and sponsored by GPSAFC

2 people are interested in this event

User Activity

No recent activity